TRICYCLIC PYRAZOLOPYRIMIDINE DERIVATIVE
    4.
    发明公开
    TRICYCLIC PYRAZOLOPYRIMIDINE DERIVATIVE 有权
    三环吡唑并嘧啶衍生物

    公开(公告)号:EP2402349A1

    公开(公告)日:2012-01-04

    申请号:EP10746224.4

    申请日:2010-02-24

    CPC分类号: A61K31/519 C07D495/16

    摘要: To provide a novel compound inhibiting the effect of HSP90, in particular a novel compound inhibiting the function of HSP90 as a chaperone protein and having antitumor activity.
    The present invention provides a pyrazolopyrimidine compound represented by formula (1) having various substituents which inhibits the ATPase activity of HSP90 and which has antitumor activity, an HSP90 inhibitor comprising a compound represented by formula (1), a medicament comprising a compound represented by formula (1), an anticancer agent comprising a compound represented by formula (1), a pharmaceutical composition comprising a compound represented by formula (1), and a method for treating cancer using a compound represented by formula (1).

    摘要翻译: 提供一种抑制HSP90作用的新化合物,特别是抑制作为伴侣蛋白的HSP90功能的新化合物,具有抗肿瘤活性。 本发明提供具有抑制HSP90的ATP酶活性的各种取代基并具有抗肿瘤活性的由式​​(1)表示的吡唑并嘧啶化合物,包含由式(1)表示的化合物的HSP90抑制剂,包含由式 (1)所示的化合物的抗癌剂,含有式(1)所示的化合物的抗癌剂,含有式(1)所示的化合物的药物组合物以及使用式(1)所示的化合物治疗癌症的方法。